Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Study Completion Date

October 31, 2000

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

methotrexate

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

RADIATION

radiation therapy

Trial Locations (4)

21287

Johns Hopkins Oncology Center, Baltimore

29203

University of South Carolina School of Medicine, Columbia

98109

Fred Hutchinson Cancer Research Center, Seattle

01655

University of Massachusetts Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00005854 - Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter